Zi Liu

6PUBLICATIONS
4CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Nanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
Identification of ISZ-sTRAIL Protein as a Potent Anticancer Agent for EML4-ALK-Positive Non-Small-Cell Lung Cancer.

|Apr 09, 2025
Anti-breast cancer activity of a novel genetically engineered fusion protein composed of HER2 affibody and proapoptotic peptide R8-KLA.

Jian Liu, Zi Liu, Junfeng Hu

|Mar 24, 2023
Synthesis and Evaluation of Piperazine-Tethered Derivatives of Alepterolic Acid as Anticancer Agents.

Zi Liu, Chenlu Xia, Nina Wang

|Jan 12, 2023
Ethoxysanguinarine Induces Apoptosis, Inhibits Metastasis and Sensitizes cells to Docetaxel in Breast Cancer Cells through Inhibition of Hakai.

Liang Ma, Xiao-Jing Xuan, Xue-Ming Chen

|Jun 08, 2022
A novel 8-hydroxyquinoline derivative induces breast cancer cell death through paraptosis and apoptosis.

Liang Ma, Xiaojing Xuan, Minghui Fan

|Sep 07, 2021
A novel nickel-modified nano-magnetite for isolation of histidine-tagged proteins expressed in Escherichia coli.

Liang Ma, Yindi Zhu, Xueming Chen

Pageof 1

Frequent Collaborators

5 joint publications

Liang Ma

2 joint publications

Guozheng Huang

1 joint publications

Nina Wang

1 joint publications

Jianguo Cao